Kidney Cancer Trial, Recruiting NCT06652009 Sponsor: Peking University First Hospital Condition: Kidney Cancer
Back to Kidney Cancer

Kidney Cancer Trial, Recruiting

NCT06652009
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with cancer of the renal pelvis (part of the kidney) or ureter (the tube connecting the kidney to the bladder), confirmed through symptoms, scans, tissue samples, urine tests, or a specialised genetic test called FISH
  • People where specialist doctors (an imaging doctor and a urologist) have assessed scans and determined a renal pelvis or ureteral cancer is present, even without a tissue sample
  • People where full body scans show the cancer has not spread to distant parts of the body
  • People who are not able to have surgery because of poor general health, inability to tolerate anaesthesia, or personal choice
  • People aged over 70 years
  • People under 70 years who have other health conditions, or where cancer has spread to nearby lymph nodes, that make major surgery unsuitable
  • People expected to live at least 6 months
  • People willing and able to follow the trial schedule and attend follow-up appointments, and who have signed a consent form agreeing to take part

Who may not be able to join:

  • People who have previously had radiotherapy to the abdomen or pelvis
  • People with other serious, uncontrolled health conditions that could interfere with following the trial plan or affect the results
  • People who have had another type of cancer within the last 5 years, unless it was a cancer likely to be fully resolved with treatment (such as certain thyroid cancers, cervical cancer in situ, certain skin cancers, or breast ductal carcinoma in situ treated with surgery)
  • People where the trial team judges that full participation in the study is unlikely (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University First Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Postoperative changes in renal function(eGFR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov